📈 69% of S&P 500 stocks beating the index - a historic record! Pick the best ones with AI.See top stocks

EU set to approve ChemChina's $43 billion bid for Syngenta: sources

Published 02/02/2017, 11:06 AM
© Reuters. A Syngenta logo is pictured in their office in Singapore
SYENF
-

By Foo Yun Chee

BRUSSELS (Reuters) - ChemChina [CNNCC.UL] is set to secure conditional EU antitrust approval for its $43 billion bid for Swiss pesticides and seeds group Syngenta (S:SYNN), the largest foreign acquisition by a Chinese company, two people familiar with the matter said on Thursday.

The deal is important for China, the world's largest agricultural market, which is seeking to secure the food supply for its huge population. Syngenta's portfolio of top-tier chemicals and patent-protected seeds would boost its potential output.

The Chinese state-owned company has agreed to minor concessions to allay the European Commission's concerns over its takeover of the world's largest pesticides maker. Regulators had been worried that the deal may lead to higher prices and fewer choices for farmers.

ChemChina will divest a couple of national product registrations, including existing products and a few in the pipeline, in more than a dozen EU countries, one of the people said.

The products are generally from ChemChina unit and Israeli crop protection company Adama while a few are from Syngenta, the person said. No plants, facilities or personnel are involved. Adama is the largest supplier of generic crop protection products in Europe.

Commission spokesman Ricardo Cardoso declined to comment. It was not immediately possible to reach ChemChina for a comment outside regular office hours. Syngenta said it has not been notified of any decision by the Commission.

The Commission may announce its approval next month, ahead of its scheduled April 12 deadline, the source said.

© Reuters. A Syngenta logo is pictured in their office in Singapore

Syngenta shares were 0.45 percent higher at 426.4 Swiss francs in late trade. The deal has already been approved by a U.S. national security panel.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.